Britannia Life Sciences Announces Closing of £5,000,000 Loan Facility
Britannia Life Sciences Announces Closing of £5,000,000 Loan Facility
- Proceeds to be used to repay Sellers' Note and acquire an additional 10% of ADSL
- Five-year term provides Company with significant financial flexibility
- 5 year term, 9.5% interest rate, no equity kickers
- 所得款项将用于偿还卖方票据并额外收购ADSL 10%的股份
- 五年期限为公司提供了极大的财务灵活性
- 5年期,利率9.5%,无股票溢价
Toronto, Ontario--(Newsfile Corp. - April 7, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) ("Britannia") is pleased to announce the closing of a £5,000,000 loan facility (the "Loan Facility").
安大略省多伦多-(Newsfile Corp.-2022年4月7日)-Britannia Life Science Inc.(CSE:BLAB)(FSE:L020)(“不列颠“)高兴地宣布结束一项500万GB的贷款安排(”贷款安排").
The proceeds of the Loan Facility will be used to repay, in full, the remaining amounts due to the vendors of Advanced Development & Safety Laboratories Limited ("ADSL") under the sellers' note agreement ("Sellers' Note") and to fund the acquisition of an additional 10% interest in ADSL ("Additional ADSL Purchase"). Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary.
贷款所得款项将用于全数偿还应付先进发展及安全实验室有限公司(“ADSL“)根据卖方票据协议(”卖家笔记“),并出资收购ADSL额外10%的权益(”额外购买ADSL在完成对ADSL的额外收购后,不列颠将拥有不列颠最大运营子公司ADSL的70%权益。
"We're tremendously pleased to complete this financing which allows us to repay the Sellers' Note in full and to further consolidate our ownership in ADSL," commented Britannia CEO Peter Shippen. "We sincerely appreciate the ongoing support and cooperation of the vendors and our shareholders in helping us achieve this important milestone which strengthens the foundation for our continued growth."
不列颠首席执行官彼得·希彭评论说:“我们非常高兴能够完成这笔融资,使我们能够全额偿还卖方的票据,并进一步巩固我们在ADSL的所有权。”我们衷心感谢供应商和我们的股东的持续支持和合作,帮助我们实现这一重要的里程碑,为我们的持续增长奠定了基础。“
The Loan Facility is being extended by an affiliate of BOOST & Co Limited, a UK-based private lender providing growth capital and venture debt to small and medium-sized enterprises.
该贷款工具是由Boost&Co Limited的一家附属公司提供的,Boost&Co Limited是一家总部位于英国的私人贷款机构,为中小企业提供增长资本和风险债务。
The Loan Facility consists of a 5-year secured term loan facility bearing interest at varying margins based on the Sterling Overnight Interbank Average (SONIA) rate. The Loan Facility was fully drawn by Britannia at closing and currently bears interest of 9.5%. There were no equity incentives provided to the lender with respect to the loan.
贷款安排由一项5年期有担保定期贷款安排组成,按英镑隔夜银行同业平均利率(SONIA)按不同利润率计息。贷款安排在成交时由不列颠全额提取,目前利息为9.5%。贷款方面没有向贷款人提供股权奖励。
Advisors
顾问
Regent Assay Limited acted as agent to Britannia in connection with the Loan Facility. Legal advice to Britannia was provided by Gowling WLG (UK) LLP and Bennett Jones LLP.
丽晶分析有限公司担任不列颠的代理,与贷款安排有关。Gowling WLG(UK)LLP和Bennett Jones LLP为不列颠提供法律咨询。
About Britannia Life Sciences Inc.
不列颠生命科学公司简介
Britannia Life Sciences Inc. is a global platform offering an integrated suite of services to assist companies along their product development journey. Britannia's services, including product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies ranging from multinationals to startups particularly in the cosmetics, food, and wellness industries. Britannia has garnered significant expertise in the development and regulatory approval of topical and edible cannabis products, including preparation and support for novel food authorizations. Britannia's head office is located at 120 Adelaide Street West, Suite 2400, Toronto, Ontario, M5H 1T1.
不列颠生命科学公司是一个全球平台,提供一整套服务,帮助公司在产品开发过程中提供帮助。Britannia的服务包括产品配方、安全评估、分析和微生物测试、全球合规性和消费者评估,服务范围从跨国公司到初创公司,特别是化妆品、食品和健康行业。不列颠在局部和可食用大麻产品的开发和监管批准方面积累了大量专业知识,包括准备和支持新的食品授权。不列颠公司的总部位于安大略省多伦多阿德莱德街西120号,2400号套房,邮编:M5H 1T1。
For inquiries or more information on Britannia's growing suite of product development, analytical testing, regulatory and compliance solutions across a range of industries, please visit or contact:
有关不列颠在一系列行业中不断增长的产品开发、分析测试、监管和合规解决方案的查询或更多信息,请访问或联系:
Peter Shippen, CEO
Tel: +1 416 930 7711 or +44 738 744 7441
Email: peter@britannia.life
首席执行官彼得·希彭
电话:+1 416 930 7711或+44 738 744 7441
电子邮件:peter@britannia.life
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问